Progyny, Inc. (PGNY) Income Statement
PGNY 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsPGNY revenue and net income
Where PGNY's revenue goes
2025Each bar shows an amount and its share of revenue. PGNY kept 4.5% of revenue as net income.
PGNY profit margins
PGNY growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +10.4% | +17.9% | +30.2% | — |
| Gross profit | +20.2% | +22.1% | +34.2% | — |
| Operating income | +26.4% | +54.0% | +59.2% | — |
| Net income | +7.7% | +24.5% | +4.7% | — |
| EPS (diluted) | −23.2% | +61.3% | +60.0% | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
PGNY quarterly EPS vs estimates
Progyny beat the analyst EPS estimate in 8 of the last 8 quarters. Next report: November 5, 2026 (estimate $0.27).
PGNY income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.29B | $1.17B | $1.09B | $786.9M | $500.6M | $344.9M | $229.7M | $105.4M | $48.6M |
| Cost of revenue | $984.2M | $913.9M | $849.8M | $619.6M | $388.5M | $274.8M | $184.2M | $86.0M | $41.2M |
| Gross profit | $304.5M | $253.4M | $238.8M | $167.3M | $112.1M | $70.1M | $45.5M | $19.4M | $7.4M |
| Sales, general & admin | $219.2M | $185.9M | $176.6M | $144.0M | $79.8M | $61.7M | $35.8M | $22.9M | $18.4M |
| Total operating expenses | $219.2M | $185.9M | $176.6M | $144.0M | $79.8M | $61.7M | $35.8M | $22.9M | $18.4M |
| Operating income | $85.3M | $67.5M | $62.2M | $23.3M | $32.3M | $8.3M | $9.7M | −$3.5M | −$11.0M |
| Interest income | $10.2M | $15.7M | $8.5M | $814,000 | — | — | $58,000 | $497,000 | $740,000 |
| Interest expense | — | — | — | $814,000 | $461,000 | $121,000 | $58,000 | $497,000 | $740,000 |
| Income before taxes | $95.4M | $83.2M | $70.7M | $24.4M | $32.4M | $8.7M | −$8.6M | −$6.9M | −$12.5M |
| Income taxes | $36.9M | $28.9M | $8.7M | −$5.9M | −$33.3M | −$37.8M | $12,000 | −$1.8M | −$3,000 |
| Net income | $58.5M | $54.3M | $62.0M | $30.4M | $65.8M | $46.5M | −$8.6M | $661,000 | −$12.5M |
| EBITDA | $100.4M | $86.4M | $73.0M | $26.0M | $33.7M | $10.3M | $11.8M | −$1.6M | −$9.4M |
| EPS (diluted) | $1.26 | $1.64 | $0.62 | $0.30 | $0.66 | $0.12 | $0.07 | $0.01 | −$2.08 |
| Gross margin | 23.6% | 21.7% | 21.9% | 21.3% | 22.4% | 20.3% | 19.8% | 18.4% | 15.2% |
| Operating margin | 6.6% | 5.8% | 5.7% | 3.0% | 6.5% | 2.4% | 4.2% | −3.3% | −22.7% |
| Net margin | 4.5% | 4.7% | 5.7% | 3.9% | 13.1% | 13.5% | −3.7% | 0.6% | −25.6% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $350.5M | $328.5M | $318.4M | $313.3M | $332.9M | $324.0M | $298.4M | $286.6M | $304.1M | $278.1M | $269.9M | $280.9M |
| Cost of revenue | $261.2M | $245.4M | $241.5M | $240.5M | $253.9M | $248.2M | $235.0M | $227.4M | $235.8M | $215.7M | $213.0M | $218.3M |
| Gross profit | $89.3M | $83.1M | $76.9M | $72.8M | $79.0M | $75.8M | $63.4M | $59.2M | $68.3M | $62.4M | $56.9M | $62.6M |
| Sales, general & admin | $49.3M | $47.7M | $62.8M | $50.2M | $54.6M | $51.6M | $47.6M | $46.8M | $47.6M | $43.9M | $43.1M | $44.4M |
| Total operating expenses | $49.3M | $47.7M | $61.7M | $51.3M | $54.6M | $51.6M | $47.6M | $46.8M | $47.6M | $43.9M | $43.1M | $44.4M |
| Operating income | $40.0M | $35.4M | $15.2M | $21.5M | $24.4M | $24.2M | $15.8M | $12.5M | $20.7M | $18.5M | $13.8M | $18.2M |
| Interest income | $1.1M | $1.5M | $2.6M | $2.4M | $2.7M | $2.4M | $1.9M | $5.5M | $816,000 | $632,000 | — | $1.0M |
| Income before taxes | $41.1M | $36.9M | $17.9M | $24.0M | $27.1M | $26.5M | $17.7M | $18.0M | $25.1M | $22.5M | $16.3M | $20.9M |
| Income taxes | $13.1M | $12.7M | $5.4M | $10.1M | $10.0M | $11.5M | $7.1M | $7.5M | $8.6M | $5.6M | $2.8M | $5.0M |
| Net income | $28.1M | $24.2M | $12.5M | $13.9M | $17.1M | $15.1M | $10.5M | $10.4M | $16.5M | $16.9M | $13.5M | $15.9M |
| EBITDA | $44.2M | $38.4M | $19.2M | $25.2M | $28.3M | $27.6M | $18.5M | $18.8M | $25.8M | $23.2M | $16.9M | $21.5M |
| EPS (diluted) | $0.34 | $0.50 | $0.14 | $0.45 | $0.19 | $0.48 | $0.42 | $0.40 | $0.43 | $0.39 | $0.13 | $0.16 |
| Gross margin | 25.5% | 25.3% | 24.1% | 23.2% | 23.7% | 23.4% | 21.3% | 20.7% | 22.5% | 22.4% | 21.1% | 22.3% |
| Operating margin | 11.4% | 10.8% | 4.8% | 6.9% | 7.3% | 7.5% | 5.3% | 4.3% | 6.8% | 6.7% | 5.1% | 6.5% |
| Net margin | 8.0% | 7.4% | 3.9% | 4.4% | 5.1% | 4.6% | 3.5% | 3.6% | 5.4% | 6.1% | 5.0% | 5.7% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in PGNY's financial statements (latest annual report filed February 27, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
PGNY financial results
In fiscal year 2025 (ended December 31, 2025), Progyny reported revenue of $1.3 billion, up 10.4% from the year before. It had net income of $58.5 million (up 7.7%), a net profit margin of 4.5%. Diluted earnings per share came to $1.26. Over five years revenue grew at an average rate of 30.2% a year.
See the PGNY stock overview for the latest quote and news, or the PGNY chart for price history and technical indicators.
PGNY income statement FAQ
What is Progyny's annual revenue?
Progyny reported total revenue of $1.3 billion for fiscal year 2025, which ended on December 31, 2025. That was up 10.4% from $1.2 billion the previous year.
Is Progyny profitable?
Yes. Progyny reported net income of $58.5 million in fiscal 2025, a net profit margin of 4.5%; its operating margin was 6.6%.
What is Progyny's gross margin?
Progyny's gross margin was 23.6% in fiscal 2025: for every $100 of revenue, Progyny kept $24 after the direct cost of its products and services.
How fast is Progyny growing?
Revenue grew 30.2% a year on average over the last five fiscal years, from $344.9 million to $1.3 billion.
What are Progyny's earnings per share?
Progyny earned $1.26 per diluted share in fiscal 2025, compared with $1.64 a year earlier.
When will Progyny report its next earnings?
Progyny is expected to report results for the quarter ending September 30, 2026 on November 5, 2026 after the market closes.
When does Progyny's fiscal year end?
Progyny's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on February 27, 2026.